SciClone Pharmaceuticals Inc - Strategic SWOT Analysis Review

SciClone Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy its summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities A list of key manufacturing facilities of the company.

Highlights

SciClone Pharmaceuticals Inc (SciClone), a subsidiary of Silver Biotech Investment Ltd, develops and commercializes products for the treatment of cancer, cardiovascular disorders and infectious diseases. The companys lead product, Zadaxin (thymalfasin) is an immunostimulatory agent indicated for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), sepsis, certain cancers, and as an immune system enhancer. SciClone also markets other pharmaceutical products in China including DC Bead, a product for the embolization of malignant hypervascularized tumors. It also has several drug candidates in various clinical development states intended for the treatment of cancer and cardiovascular diseases. The company has presence in Beijing and Shanghai in China; Hong Kong and Vietnam. SciClone is headquartered in Foster City, California, the US.

SciClone Pharmaceuticals Inc Key Recent Developments

Aug 09,2017: SciClone Reports Second Quarter 2017 Financial Results
May 10,2017: SciClone Reports First Quarter 2017 Financial Results
Mar 06,2017: SciClone Reports 2016 Financial Results And 2017 Outlook

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with its detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.



List of Tables 4
List of Figures 4
Section 1 - About the Company 5
SciClone Pharmaceuticals Inc - Key Facts 5
SciClone Pharmaceuticals Inc - Key Employees 6
SciClone Pharmaceuticals Inc - Key Employee Biographies 7
SciClone Pharmaceuticals Inc - Major Products and Services 8
SciClone Pharmaceuticals Inc - History 9
SciClone Pharmaceuticals Inc - Company Statement 11
SciClone Pharmaceuticals Inc - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 Company Analysis 15
Company Overview 15
SciClone Pharmaceuticals Inc - Business Description 16
SciClone Pharmaceuticals Inc - SWOT Analysis 17
SWOT Analysis - Overview 17
SciClone Pharmaceuticals Inc - Strengths 17
SciClone Pharmaceuticals Inc - Weaknesses 18
SciClone Pharmaceuticals Inc - Opportunities 19
SciClone Pharmaceuticals Inc - Threats 20
SciClone Pharmaceuticals Inc - Key Competitors 21
Section 3 Companys Lifesciences Financial Deals and Alliances 22
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 22
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 23
SciClone Pharmaceuticals Inc, Recent Deals Summary 24
Section 4 Companys Recent Developments 25
Aug 09, 2017: SciClone Reports Second Quarter 2017 Financial Results 25
May 10, 2017: SciClone Reports First Quarter 2017 Financial Results 27
Mar 06, 2017: SciClone Reports 2016 Financial Results And 2017 Outlook 29
Section 5 Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List Of Tables


SciClone Pharmaceuticals Inc, Key Facts 5
SciClone Pharmaceuticals Inc, Key Employees 6
SciClone Pharmaceuticals Inc, Key Employee Biographies 7
SciClone Pharmaceuticals Inc, Major Products and Services 8
SciClone Pharmaceuticals Inc, History 9
SciClone Pharmaceuticals Inc, Subsidiaries 14
SciClone Pharmaceuticals Inc, Key Competitors 21
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 22
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 23
SciClone Pharmaceuticals Inc, Recent Deals Summary 24

List Of Figures


SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 22
SciClone Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 23

SciClone Pharmaceuticals Inc - Strategic SWOT Analysis Review

SciClone Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

SciClone Pharmaceuticals Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

SciClone Pharmaceuticals Inc Company Profile is a detailed strategic and analytical report on SciClone Pharmaceuticals Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Constellation Pharmaceuticals Inc (CNST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Constellation Pharmaceuticals Inc (Constellation) is a clinical biopharmaceutical company that focuses to develop novel therapeutics for the treatment of serious unmet medical needs in patients with cancers associated with abnormal

USD 250 View Report

Cannabics Pharmaceuticals Inc (CNBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available